President Xi Jinping called on the country's medical workers on Aug 18 to adhere to a people-first approach and make new contributions to improving people's health.
Noted respiratory disease expert Wang Chen advised Chinese public health authorities to expand the scope of vaccination for the flu before October to prevent the possible concurrence of the flu season with the COVID-19 pandemic, which may pose a serious public health risk.
On June 29, 2020, the Regulations on Supervision and Administration of Cosmetics (Decree No.727 of the State Council of the People's Republic of China) (hereinafter referred to as the Regulations), was promulgated, and shall take effect as from Jan 1, 2021.
The Eleventh Conference of the Chinese Pharmacopoeia Commission Executive Committee Held in Beijing — Review and Approve the Draft of ChP 2020 Edition
On April 9 the 11th Conference of the Chinese Pharmacopoeia Commission (ChPC) Executive Committee was held in Beijing for a briefing on ChPC's compilation of the ChP 2020 Edition,as well as the deliberation and approval of its draft.
An inactivated COVID-19 vaccine candidate developed by China is safe and generates an immune response, according to data from clinical trials published in The Journal of the American Medical Association this week.
A senior expert of the World Health Organization (WHO) said on Aug 13 that although there are some cases suggesting that an individual may have been re-infected with COVID-19, it's still not confirmed.